StonvexLoading…
StonvexStonvexStonvexCore line items from NROM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $15.15M | $14.37M | $14.45M | $13.88M |
Operating Income | $1.48M | $3.44M | $427.72K | $1.74M |
Net Income | $-3.17K | $1.46M | $-1.31M | $509.46K |
EPS (Diluted) | $0.00 | $0.07 | $-0.06 | $0.02 |
Total Assets | $16.77M | $18.48M | $18.34M | $19.38M |
Total Liabilities | $14.55M | $16.29M | $17.63M | Not available |
Cash & Equivalents | $793.59K | $872.34K | $785.52K | $1.26M |
Free Cash Flow OCF − CapEx | Not available | $1.55M | $-477.99K | $69.15K |
Shares Outstanding | 22.22M | 22.22M | 22.22M | 22.22M |